|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
3R01CA082036-09S1
|
$69,244
|
$69,244
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
5R01CA082036-09
|
$443,347
|
$443,347
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Viral Oncology Training Grant
|
2T32CA009111-31A2
|
$318,261
|
$31,826
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Role of MAPK signaling in Kaposi's sarcoma-associated herpersvirus pathogenesis
|
1F31CA132560-01A1
|
$27,772
|
$27,772
|
Dyson, Ossie
|
EAST CAROLINA UNIVERSITY
|
|
Characterization of the gamma HV68 v-cyclin
|
5R01CA087650-07
|
$316,022
|
$158,011
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
|
Improved Diagnosis of Kaposi's Sarcoma Herpes Virus Infection
|
1R43CA134172-01
|
$112,978
|
$112,978
|
Houghton, Michael
|
EPIPHANY BIOSCIENCES, INC.
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S4
|
$9,979,932
|
$99,799
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S5
|
$60,810
|
$608
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S6
|
$264,000
|
$2,640
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
VIRUS-HOST INTERACTIONS IN CANCER
|
5T32CA009031-32
|
$306,523
|
$76,631
|
KIEFF, ELLIOTT
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Role of KSHV in AIDS Malignancies
|
5P01CA113239-03
|
$1,118,954
|
$1,118,954
|
HAYWARD, GARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Regulation of Cellular Proteins by KSHV RAP and RTA
|
5R01CA073585-12
|
$397,126
|
$397,126
|
HAYWARD, GARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-46
|
$7,420,697
|
$371,035
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Bim regulation by HHV-8 vIRF-1
|
1R21CA136356-01
|
$184,500
|
$184,500
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
Studies of HHV-8 vIL-6 Function
|
5R01CA076445-09
|
$348,813
|
$348,813
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
HHV-8 vGPCR Signaling in Virus Biology
|
5R21CA119887-02
|
$196,800
|
$196,800
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
Prognostic Markers for HIV-Postive Diffuse Large B-Cell Lymphoma
|
1R01CA134234-01
|
$500,000
|
$500,000
|
Chao, Chun
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
Lymphoproliferative Disorders in Primary Immunodeficiencies
|
1R01CA122539-01A2
|
$314,363
|
$314,363
|
Routes, John
|
MEDICAL COLLEGE OF WISCONSIN
|
|
An Animal Model for Kaposi's Sarcoma
|
5K08CA103858-05
|
$133,083
|
$133,083
|
PARSONS, CHRISTOPHER
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Role of Chemokine Receptor ORF74 in Angioproliferation
|
5R01CA109259-05
|
$329,470
|
$329,470
|
LIRA, SERGIO
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
non-AIDS Lymphomas
|
Z01 CP010150-10078
|
$796,500
|
$79,650
|
Engels, Eric
|
DCEG (NCI)
|
|
Prostate cancer, infections & immunity
|
Z01 CP010150-10290
|
$28,865
|
$2,887
|
Engels, Eric
|
DCEG (NCI)
|
|
Cancer risk in solid organ transplant recipients and endstage renal disease
|
Z01 CP010150-10362
|
$318,791
|
$63,758
|
Engels, Eric
|
DCEG (NCI)
|
|
Anatomic Pathology Residency Program
|
Z01 BC 010684
|
$1,300,000
|
$65,000
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents
|
Z01 BC 006174
|
$190,292
|
$28,544
|
Marquez, Victor
|
CCR (NCI)
|
|
HIV AIDS cancer match, U.S.
|
Z01 CP010176-10071
|
$340,213
|
$34,021
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
HIV/AIDS Lymphomas
|
Z01 CP010176-10074
|
$586,184
|
$175,855
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
KSHV/HHV8 in sickle cell and other Ugandan populations
|
Z01 CP010176-10076
|
$126,127
|
$126,127
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
Classical KS case-control studies
|
Z01 CP010176-10077
|
$339,387
|
$339,387
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
KS gene expression & clonality
|
Z01 CP010176-10082
|
$78,036
|
$15,607
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
AIDS cancer match, non-U.S.
|
Z01 CP010176-10084
|
$188,362
|
$94,181
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
Urban Health Study
|
Z01 CP005782-10067
|
$517,470
|
$129,367
|
O'Brien, Thomas
|
DCEG (NCI)
|
|
Molecular Diagnostics Core Laboratory
|
Z01 BC 011079
|
$1,067,000
|
$21,340
|
Raffeld, Mark
|
CCR (NCI)
|
|
Identification of Gene Polymorphisms Associated with Infectious Diseases
|
Z01 BC 010297
|
$554,639
|
$55,464
|
Winkler, Cheryl Ann
|
CCR (NCI)
|
|
Study of tumor pathogenesis and development of therapies for AIDS-malignancies
|
Z01 BC 010885
|
$497,035
|
$447,332
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Clinical trials of patients with AIDS-related malignancies
|
Z01 BC 010888
|
$679,281
|
$475,497
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses
|
Z01 SC 010357
|
$752,317
|
$451,391
|
Zheng, Zhi-Ming
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
2P30CA016087-28
|
$2,640,338
|
$26,403
|
CARROLL, WILLIAM
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
OHSU Cancer Institute
|
3P30CA069533-12S1
|
$69,612
|
$10,442
|
DRUKER, BRIAN
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
OHSU Cancer Institute
|
5P30CA069533-12
|
$1,145,093
|
$171,764
|
DRUKER, BRIAN
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
Mechanisms of KSHV-Induced Cellular Transformation
|
5R01CA099906-05
|
$234,807
|
$234,807
|
MOSES, ASHLEE
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
Anti-viral IL6 approach to mitigate KSHV-related disease
|
1R01CA132638-01A1
|
$643,832
|
$321,916
|
WONG, SCOTT
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
Rhesus HHV-8 homologue in AIDS-related malignancies
|
5R01CA075922-12
|
$595,989
|
$595,989
|
WONG, SCOTT
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
Antigens of Kaposi's sarcoma associated herpesvirus
|
2R01CA075911-12A1
|
$310,171
|
$310,171
|
Chandran, Bala
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
Role of Cyclooxygenase-2 and PGE2 in KSHV pathogenesis
|
1R21CA128560-01A2
|
$190,575
|
$190,575
|
Sharma-Walia, Neelam
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
Chromosome 6p21-24 Markers in HIV-Related Kaposi Sarcoma
|
5R01CA106168-05
|
$253,662
|
$253,662
|
Kaslow, Richard
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Comprehensive Cancer Center Core Support Grant
|
3P30CA013148-37S1
|
$72,878
|
$1,458
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Comprehensive Cancer Center Core Support Grant
|
3P30CA013148-37S2
|
$250,000
|
$5,000
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Comprehensive Cancer Center Core Support Grant
|
5P30CA013148-37
|
$5,700,309
|
$114,006
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Immune evasion by KSHV
|
5R01CA108447-05
|
$232,411
|
$232,411
|
COSCOY, LAURENT
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
Total relevant funding to HHV8 for this search: $25,642,169
|